Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
AbbVie Inc.’s stock fell 0.5% early Monday, after the biotech lowered its first-quarter guidance to reflect the dilutive impact of...
Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys AG for 2.7 billion euros ($2.9...
The controlling shareholder of weight-loss drug maker Novo Nordisk on Monday said it’s buying a provider of drug manufacturing for...
Cancer drug company CG Oncology Inc. priced its initial public offering above its estimated range and added three million shares...
GSK on Tuesday said it had struck a deal to acquire asthma drug developer Aiolos Bio for up to $1.4...
Losing weight is one of the top New Year’s resolutions that people make year after year, and with good reason....
Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission. The Irvine, Calif.-based...
Moderna Inc.’s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer upgraded the stock to the equivalent...
French pharmaceuticals giant Sanofi SAN, -0.44% on Thursday said it would be halting development of a promising cancer treatment after...